{
    "Title": "Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a",
    "URL": "https://doi.org/10.1371/journal.pntd.0004926",
    "Published": "August 17, 2016",
    "Subject_Areas": [
        "Vaccines",
        "Typhoid",
        "Salmonella typhi",
        "Vaccine development",
        "Antibodies",
        "Vaccination and immunization",
        "Blood",
        "Fevers"
    ],
    "Authors": {
        "Thomas C. Darton": [
            "Oxford Vaccine Group, Department of Paediatrics, and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom"
        ],
        "Claire Jones": [
            "Oxford Vaccine Group, Department of Paediatrics, and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom"
        ],
        "Christoph J. Blohmke": [
            "Oxford Vaccine Group, Department of Paediatrics, and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom"
        ],
        "Claire S. Waddington": [
            "Oxford Vaccine Group, Department of Paediatrics, and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom"
        ],
        "Liqing Zhou": [
            "Oxford Vaccine Group, Department of Paediatrics, and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom"
        ],
        "Anna Peters": [
            "Oxford Vaccine Group, Department of Paediatrics, and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom"
        ],
        "Kathryn Haworth": [
            "Oxford Vaccine Group, Department of Paediatrics, and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom"
        ],
        "Rebecca Sie": [
            "Oxford Vaccine Group, Department of Paediatrics, and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom"
        ],
        "Christopher A. Green": [
            "Oxford Vaccine Group, Department of Paediatrics, and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom"
        ],
        "Catherine A. Jeppesen": [
            "Oxford Vaccine Group, Department of Paediatrics, and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom"
        ],
        "Maria Moore": [
            "Oxford Vaccine Group, Department of Paediatrics, and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom"
        ],
        "Ben A. V. Thompson": [
            "Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom"
        ],
        "Tessa John": [
            "Oxford Vaccine Group, Department of Paediatrics, and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom"
        ],
        "Robert A. Kingsley": [
            "Microbial Pathogenesis Group, Wellcome Trust Sanger Institute, Hinxton, United Kingdom"
        ],
        "Ly-Mee Yu": [
            "Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom"
        ],
        "Merryn Voysey": [
            "Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom"
        ],
        "Zoe Hindle": [
            "Emergent Product Development UK Ltd, Emergent BioSolutions, Wokingham, United Kingdom"
        ],
        "Stephen Lockhart": [
            "Emergent Product Development UK Ltd, Emergent BioSolutions, Wokingham, United Kingdom"
        ],
        "Marcelo B. Sztein": [
            "Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America"
        ],
        "Gordon Dougan": [
            "Microbial Pathogenesis Group, Wellcome Trust Sanger Institute, Hinxton, United Kingdom"
        ],
        "Brian Angus": [
            "Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom"
        ],
        "Myron M. Levine": [
            "Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America"
        ],
        "Andrew J. Pollard": [
            "Oxford Vaccine Group, Department of Paediatrics, and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom"
        ]
    }
}